Diagnosing depression in MS in the face of overlapping symptoms

International MS Journal

Volumn 17, Issue 1, 2010, Pages 3-5

  Patten, S B ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; DESIPRAMINE; FLUOXETINE; MOCLOBEMIDE; PAROXETINE; PLACEBO; SERTRALINE;

BECK DEPRESSION INVENTORY; CHICAGO MULTISCALE DEPRESSION INVENTORY; CLINICAL TRIAL; COGNITIVE THERAPY; DEPRESSION INVENTORY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DOSE RESPONSE; DRUG MEGADOSE; HEPATITIS C; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; MELANOMA; MULTIPLE SCLEROSIS; NOTE; PATHOPHYSIOLOGY; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; DEPRESSION;

DEPRESSION; DEPRESSIVE DISORDER; HUMANS; MULTIPLE SCLEROSIS;

EID: 77954844363     PISSN: 13528963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (19)

1. Patten SB, Beck CA, Williams JVA, Barbui C, Metz L. Major depression in multiple sclerosis: a population-based perspective. Neurology 2003; 61:1524-1527
2. Lobentanz IS, Asenbaum S, Vass K, Sauter C, Klösch G, Kollegger H et al. Factors influencing quality of life in multiple sclerosis: disability, depressive mood, fatigue and sleep quality. Acta Neurologica Scandinavica 2004; 110:6-13
3. Schiffer RB, Wineman NM. Antidepressant pharmacotherapy of depression associated with multiple sclerosis. Am J Psychiatry 1990; 147:1493-1497
4. Mohr DC, Boudewyn AC, Goodkin DE, Bostrom A, Epstein L. Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J Cons Clin Psychol 2001; 69:942-949
5. Ehde DM, Kraft GH, Chwastiak L, Sullivan MD, Gibbons LE, Bombardier CH et al. Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis. Gen Hosp Psychiatry 2008; 30:40-48
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR). 2000. Washington, American Psychiatric Association.
7. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. 1. Frequency, patterns, and prediction. Neurology 1991; 41:685-691
8. Hadjimichael O, Vollmer T, Oleen-Burkey M. Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey. Health Qual Life Outcomes 2008; 6:100.
9. Bamer AM, Johnson KL, Amtmann D, Kraft GH. Prevalence of sleep problems in individuals with multiple sclerosis. Mult Scler 2008; 14:1127-1130
10. Mohr DC, Goodkin DE, Likosky W, Beutler L, Gatto N, Langan MK. Identification of Beck Depression Inventory items related to multiple sclerosis. J Behav Med 1997; 20:407-414
11. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009;65:732-741.
12. Zabad RK, Patten SB, Metz LM. The association of depression with disease course in multiple sclerosis. Neurology 2005; 64:359-360
13. Mostert JP, Admiraal-Behloul F, Hoogduin JM, Luyendijk J, Heersema DJ, van Buchem MA et al. Effects of fluoxetine on disease activity in relapsing multiple sclerosis: a doubleblind, placebo-controlled, exploratory study. J Neurol Neurosurg Psychiatry 2008; 79:1027-1031
14. Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity. A literature revew. Arch Intern Med 2003; 163:2433-2445
15. Eisenberger NI, Lieberman MD, Williams KD. Does rejection hurt? An FMRI study of social exclusion. Science 2003; 302:290-292
16. Sanfey AG, Rilling JK, Aronson JA, Nystrom LE, Cohen JD. The neural basis of economic decision-making in the ultimatum game. Science 2003; 300:1755-1758
17. O'Connor M-F, Wellisch DK, Stanton AL, Eisenberger NI, Irwin MR, Lieberman JA. Craving love? Enduring grief activates brain's reward center. NeuroImage 2008; 42:969-972
18. Capuron L, Pagnoni G, Demetrashvili M, Woolwine BJ, Nemeroff CB, Berns GS et al. Anterior cingulate activation and error processing during interferon-alpha treatment. Biol Psychiatry 2005; 58:190-196
19. Parker KJ, Schatzberg AF, Lyons DM. Neuroendocrine aspects of hypercortisolism in major depression. Horm Behav 2003; 43:60-66